Literature DB >> 18155898

Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis.

Luigino Dal Maso1, Mauro Lise, Paola Zambon, Emanuele Crocetti, Diego Serraino, Fulvio Ricceri, Marina Vercelli, Vincenzo De Lisi, Giovanna Tagliabue, Massimo Federico, Fabio Falcini, Tiziana Cassetti, Andrea Donato, Mario Fusco, Mario Budroni, Stefano Ferretti, Rosario Tumino, Silvano Piffer, Francesco Bellù, Lucia Mangone, Adriano Giacomin, Susanna Vitarelli, Silvia Franceschi.   

Abstract

We conducted in Italy a study to evaluate trends of primary liver cancer (PLC) and to disentangle the period from birth-cohort effects on PLC incidence. Cases aged<80 years and diagnosed between 1988 and 2002 in 20 areas covered by population-based Cancer Registries were included. Age-standardised incidence rates and age-period-cohort effects were estimated. In 1998-2002, incidence rates of PLC were 21.1/100,000 men and 6.0/100,000 women. In both genders, incidence rates increased slightly between 1988-1992 and 1993-1997 but did not rise thereafter. Amongst men, PLC risk increased in every cohort born after 1913 and the rise became steeper for cohorts born in 1948. In women, an upward trend appeared only in the cohorts born after 1953. Incidence of PLC over the last two decades in Italy did not substantially change but huge geographical variability emerged, mainly due to different times and modalities of spread of hepatitis C virus.

Entities:  

Mesh:

Year:  2007        PMID: 18155898     DOI: 10.1016/j.ejca.2007.11.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

Authors:  Shan Gao; Wan-Shui Yang; Freddie Bray; Puthiery Va; Wei Zhang; Jing Gao; Yong-Bing Xiang
Journal:  Eur J Epidemiol       Date:  2011-12-10       Impact factor: 8.082

2.  Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis.

Authors:  Xiaohong Jiang; Sai Yi Pan; Margaret de Groh; Shiliang Liu; Howard Morrison
Journal:  J Gastrointest Oncol       Date:  2011-12

3.  Combination of individualized local control and target-specific agent to improve unresectable liver cancer managements: a matched case-control study.

Authors:  Jiaping Li; Fujun Zhang; Jianyong Yang; Yingqiang Zhang; Yu Wang; Wenzhe Fan; Yonghui Huang; Wei Wang; Henry Ran; Shi Ke
Journal:  Target Oncol       Date:  2014-10-08       Impact factor: 4.493

4.  Multiple target-specific molecular imaging agents detect liver cancer in a preclinical model.

Authors:  S Ke; F Zhang; W Wang; X Qiu; J Lin; A G Cameron; C Zou; X Gao; C Zou; V F Zhu; M Li
Journal:  Curr Mol Med       Date:  2012-09       Impact factor: 2.222

5.  International trends in primary liver cancer incidence from 1973 to 2007.

Authors:  Yue Zhang; Jian-Song Ren; Ju-Fang Shi; Ni Li; Yu-Ting Wang; Chunfeng Qu; Yawei Zhang; Min Dai
Journal:  BMC Cancer       Date:  2015-03-04       Impact factor: 4.430

6.  Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Fang Wang; Sumaira Mubarik; Yu Zhang; Lu Wang; Yafeng Wang; Chuanhua Yu; Hao Li
Journal:  Int J Environ Res Public Health       Date:  2019-08-12       Impact factor: 3.390

7.  Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy.

Authors:  Daniele Lombardo; Carlo Saitta; Domenico Giosa; Francesca Casuscelli Di Tocco; Cristina Musolino; Giuseppe Caminiti; Valeria Chines; Maria Stella Franzè; Angela Alibrandi; Giuseppe Navarra; Giovanni Raimondo; Teresa Pollicino
Journal:  Oncol Lett       Date:  2020-01-22       Impact factor: 2.967

8.  Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis.

Authors:  Yang Sun; Jie Chang; Xin Liu; Chaojie Liu
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.